Compound 765
Identifiers
- Canonical SMILES:
CCN(C1CN(C1)C(=O)OC(C)(C)C)C(=O)C1=C(C(C)C)N2[C@H](c3ccc(Cl)cc3)[C@@](C)(N=C2S1)c1ccc(Cl)cc1
- IUPAC name:
tert-butyl 3-[[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-ethylamino]azetidine-1-carboxylate
- InChi:
InChI=1S/C32H38Cl2N4O3S/c1-8-37(24-17-36(18-24)30(40)41-31(4,5)6)28(39)26-25(19(2)3)38-27(20-9-13-22(33)14-10-20)32(7,35-29(38)42-26)21-11-15-23(34)16-12-21/h9-16,19,24,27H,8,17-18H2,1-7H3/t27-,32+/m1/s1
- InChiKey:
KJIWVAPUBWVPPA-ZUKKLESISA-N
External links
58006890 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.92 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 628.20 g/mol | |||
HBA | 7 | |||
HBD | 0 | |||
HBA + HBD | 7 | |||
AlogP | 6.92 | |||
TPSA | 65.45 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008072655 | 211 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.92 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4012 | RO-5045337 | DB14793 | |
0.3929 | Levamisole | DB00848 | |
0.3891 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.3625 | Cefaclor | DB00833 | |
0.3616 | Cephaloglycin | DB00689 | |
0.3603 | ONC-201 | DB14844 | |
0.3589 | Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate | DB04692 | |
0.3580 | Cefoxitin | DB01331 | |
0.3508 | (2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid | DB08706 | |
0.3478 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.3477 | Cephalexin | DB00567 | |
0.3476 | Cefiderocol | DB14879 | |
0.3453 | Cefadroxil | DB01140 | |
0.3433 | (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one | DB08710 | |
0.3417 | (5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one | DB07017 |